Transgenic SOD1 animal models that develop robust ALS-like phenotypes have been created and have been used extensively for preclinical drug development, but instead of providing clear insight to the pathogenesis of ALS, these animal models have often been the source of apparent confounding outcomes. The gene discussed is SOD1; the disease is amyotrophic lateral sclerosis.